Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,727 | -8,162 | -6,374 | -4,253 | -1,678 |
| Depreciation Amortization | 53 | 213 | 160 | 108 | 55 |
| Accounts receivable | 122 | -115 | -15 | 90 | 68 |
| Other Working Capital | -59 | -337 | -156 | -422 | -328 |
| Other Operating Activity | 3 | 634 | 397 | 148 | 57 |
| Operating Cash Flow | $-1,608 | $-7,767 | $-5,988 | $-4,329 | $-1,827 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 13,155 | 4,361 | 1,426 | 1,030 |
| Other Financing Activity | -137 | -884 | -265 | -249 | -192 |
| Financing Cash Flow | $-137 | $12,271 | $4,097 | $1,177 | $838 |
| Beginning Cash Position | 11,076 | 6,572 | 6,572 | 6,572 | 6,572 |
| End Cash Position | 9,331 | 11,076 | 4,680 | 3,419 | 5,583 |
| Net Cash Flow | $-1,745 | $4,504 | $-1,892 | $-3,152 | $-989 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,608 | -7,767 | -5,988 | -4,329 | -1,827 |
| Free Cash Flow | -1,608 | -7,767 | -5,988 | -4,329 | -1,827 |